Cronin, O., Forsyth, L., Goodman, K., Lewis, S. C., Keerie, C., Walker, A., Porteous, M., Cetnarskyj, R., Ranganath, L. R., Selby, P. L., Hampson, G., Chandra, R., Ho, S., Tobias, J. H., Young-Min, S., McKenna, M. J., Crowley, R. K., Fraser, W. D., Gennari, L., et al. (2019). Zoledronate in the prevention of Paget’s (ZiPP): Protocol for a randomised trial of genetic testing and targeted zoledronic acid therapy to prevent SQSTM1-mediated Paget’s disease of bone. BMJ Open, 9(9). https://doi.org/10.1136/BMJOPEN-2019-030689